fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

STI and HIV screening decreased while positive test results increased during COVID-19

Written by | 3 Apr 2023

New research from Boston Medical Center found that sexually transmitted infection (STI) and HIV testing declined at the onset of the COVID-19 pandemic, while there was an increase… read more.

Database analysis of commercially available STI tests supports vaginal swabs as most reliable detection method

Written by | 30 Mar 2023

Researchers conducted a meta-analysis of multiple databases from 1995-2021 to assess the diagnostic sensitivity of commercially available tests that use vaginal swabs versus urine specimens to detect chlamydia,… read more.

Simplified HIV treatment options just as effective: Major clinical trial

Written by | 24 Feb 2023

Two newer simplified treatment options are at least as effective as current approaches, according to the results of a world-first international clinical trial into second-line HIV therapy led… read more.

Common heartburn drugs could speed up TB treatment

Written by | 10 Feb 2023

The findings, published in Proceedings of the National Academy of Sciences (PNAS) today, may mean TB can be cured with shorter treatments. TB typically takes months to treat with multiple… read more.

Improved diagnostic tools needed for chronic hepatitis B patients

Written by | 7 Jan 2023

A group of international researchers is calling for revised guidelines to help improve access to hepatitis B treatment in Africa. Hepatitis B is a highly endemic virus in Africa… read more.

Third of long COVID patients suffer persistent smell loss, study finds

Written by | 22 Dec 2022

Smell loss is one of the most prevalent symptoms of long Covid according to a new study from the University of East Anglia. New research published today reveals… read more.

Trial on safety and immunogenicity of Ebola vaccines yields promising results

Written by | 17 Dec 2022

Ebola epidemics occur periodically in various sub-Saharan African countries. While vaccines exist and have already received WHO Prequalification[1] against the Zaire ebolavirus species, it is essential to pursue and intensify efforts to… read more.

New single-dose treatment for sleeping sickness could help eliminate transmission of the disease by 2030

Written by | 3 Dec 2022

A new, single-dose, oral treatment for sleeping sickness is as effective as current treatments and could be a key factor in eliminating disease transmission by 2030, suggests a… read more.

Early HIV diagnosis and treatment important for better long-term health outcomes

Written by | 30 Oct 2022

Starting antiretroviral treatment (ART) early in the course of HIV infection when the immune system is stronger results in better long-term health outcomes compared with delaying ART, according… read more.

COVID-19 increases risks of neurological problems

Written by | 30 Sep 2022

Persons infected with the COVID-19 virus are at an increased risk of developing  neurological conditions in the first year after infection, researchers reported on Sept. 22 in Nature… read more.

Chlamydia’s stealthy cloaking device identified

Written by | 27 Sep 2022

Chlamydia, the leading cause of sexually transmitted bacterial infections, evades detection and elimination inside human cells by use of a cloaking device. But Duke University researchers have grasped… read more.

Monkeypox linked to encephalitis or confusion in some patients

Written by | 11 Sep 2022

Monkeypox can sometimes lead to neurological complications such as encephalitis (brain inflammation), confusion or seizures, finds a new review of evidence led by a UCL researcher. Several studies… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.